Futura Medical PLC (LON:FUM) has signed a five-year licensing agreement with a Zagreb-based firm that will see its CSD500 condoms distributed in seven territories in south-east Europe.
The deal with Milsing is the company’s second in seven days.
Last Monday (June 13) the AIM-listed group said it had linked up with TTK Protective Devices, part of the conglomerate TTK Group and the maker of Skore, India’s biggest condom brand.
Futura said this Milsing tie-up is in line with strategy of licensing CSD500 to regional distributors in order to build a global distribution network. No financial details were given.
Chief executive James Barder told investors: “We are delighted to sign this exclusive agreement with Milsing for the marketing of CSD500 in Southeast Europe.
“It marks further progress to our strategy to license CSD500 with leading regional distributors in order to build a global distribution network.
“Milsing is a dynamic company and is well placed to maximise the potential of CSD500."